Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Cancer, Cancer, Orthopedic |
| Therapuetic Areas: | Oncology, Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | April 2009 |
| End Date: | April 2013 |
A Phase I/II Randomized, Double-blind, Controlled Study to Evaluate Efficacy and Safety of Vitamin D on Bone Mineral Density and Markers of Bone Resorption in Aromatase Inhibitor-induced Bone Loss in Women With Breast Cancer.
Aromatase inhibitors are potent suppressors of breast cancer growth, but side effects
include bone loss, fractures, arthralgias and myalgias. We hypothesize vitamin D
administration might be beneficial in treating these symptoms and to protect bone.
We found this trial at
1
site
Stanford university Hospital and Clinics Throughout our history, we have pioneered medical advances that save...
Click here to add this to my saved trials
